Aurinia Pharmaceuticals Inc Cash Flow Reinvestment Rate
Aurinia Pharmaceuticals Inc cash flow reinvestment rate. Aurinia Pharmaceuticals Inc (AUPH) has a Cash Flow Reinvestment Rate of 1.46x as of June 2026, reinvesting $76.24 Million (capex $179.00 plus investments $76.24 Million) from operating cash flow of $52.17 Million. Explore AUPH operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Aurinia Pharmaceuticals Inc (2024–2025)
Cash flow reinvestment rate of Aurinia Pharmaceuticals Inc from 2024 to 2025. Historical reinvestment intensity for Aurinia Pharmaceuticals Inc across 2 annual periods. Explore Aurinia Pharmaceuticals Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Aurinia Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2024–2025)
Aurinia Pharmaceuticals Inc cash flow reinvestment rate by year from 2024 to 2025. Year-by-year capital reinvestment analysis for Aurinia Pharmaceuticals Inc. For the full cash flow conversion analysis, see Aurinia Pharmaceuticals Inc (AUPH) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | $32.77 Million | $135.66 Million | $252.00K | ▼ -72.9% |
| 2024 | 0.89x | $39.54 Million | $44.39 Million | $281.00K | — |